Agilent Technologies, Inc. $A Shares Purchased by Live Oak Private Wealth LLC

Live Oak Private Wealth LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 12.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,280 shares of the medical research company’s stock after purchasing an additional 6,722 shares during the quarter. Live Oak Private Wealth LLC’s holdings in Agilent Technologies were worth $6,871,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in A. OP Asset Management Ltd acquired a new stake in shares of Agilent Technologies in the first quarter valued at $5,964,000. Assenagon Asset Management S.A. lifted its stake in Agilent Technologies by 26.5% during the 1st quarter. Assenagon Asset Management S.A. now owns 42,388 shares of the medical research company’s stock worth $4,831,000 after acquiring an additional 8,886 shares in the last quarter. Godsey & Gibb Inc. boosted its holdings in Agilent Technologies by 3.0% during the 1st quarter. Godsey & Gibb Inc. now owns 174,068 shares of the medical research company’s stock valued at $19,840,000 after acquiring an additional 5,089 shares during the period. Leeward Investments LLC MA boosted its holdings in Agilent Technologies by 12.3% during the 1st quarter. Leeward Investments LLC MA now owns 101,927 shares of the medical research company’s stock valued at $11,618,000 after acquiring an additional 11,173 shares during the period. Finally, Krilogy Financial LLC grew its position in Agilent Technologies by 3.2% in the 1st quarter. Krilogy Financial LLC now owns 6,553 shares of the medical research company’s stock valued at $775,000 after acquiring an additional 202 shares in the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $131.42 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The stock has a market cap of $37.12 billion, a PE ratio of 26.39, a price-to-earnings-growth ratio of 2.25 and a beta of 1.26. The firm has a fifty day moving average price of $122.22 and a 200 day moving average price of $126.32.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the company posted $1.31 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Analysts Set New Price Targets

Several analysts have recently issued reports on A shares. Morgan Stanley reduced their price target on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. HSBC cut their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. TD Cowen raised their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $161.27.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.